Gainers
- Siyata Mobile Inc. SYTA shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories.
- Trupanion, Inc. TRUP surged 39% to close at $155.41. Chewy expanded into pet insurance in partnership with Trupanion.
- TESSCO Technologies Incorporated TESS gained 31% to close at $6.77 after Lakeview Investment Group proposed to buy the company for $7.50 per share in cash.
- Novavax, Inc. NVAX climbed 28.9% to close at $182.85.
- Vaxxinity, Inc. VAXX gained 24.5% to close at $9.11. B of A Securities, on Monday, initiated coverage on Vaxxinity with a Buy rating and announced a price target of $21.
- Nemaura Medical Inc. NMRD surged 21.1% to settle at $4.99. Nemaura Medical completed initial shipment of CGM devices to UK licensee.
- Jumia Technologies AG JMIA jumped 20.8% to settle at $13.37. Jumia said 2021 Black Friday GMV reached $150 million, up 30% year over year.
- Elevation Oncology, Inc. ELEV shares rose 20.7% to settle at $5.25. Elevation Oncology, last month, posted a Q3 loss of $0.53 per share.
- Nam Tai Property Inc. NTP gained 20.4% to close at $12.04.
- Adagene Inc. ADAG surged 20.3% to settle at $9.95. Adagene announced clinical data on ADG116, and ADG106, in two poster presentations at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress 2021.
- Statera Biopharma, Inc. STAB gained 19.9% to close at $2.41. Statera Biopharma recently said the FDA lifted clinical hold on Entolimod.
- Neonode Inc. NEON jumped 19.5% to settle at $9.85. Neonode, last month, posted a Q3 loss of $0.15 per share.
- Aterian, Inc. ATER gained 19.2% to close at $5.47.
- Adagio Therapeutics, Inc. ADGI surged 19.1% to settle at $38.73. The company was granted US Patent #11,192,940 'Compounds specific to coronavirus S protein and uses thereof.'
- Design Therapeutics, Inc. DSGN rose 18% to settle at $19.71.
- MeiraGTx Holdings plc MGTX gained 17.8% to close at $20.09 after the company announced preliminary data from the AQUAx Phase 1 clinical trial of AAH-haQP1 for the treatment of grade 2/3 radiation-induced xerostomia.
- X Financial XYF rose 17.8% to settle at $3.97.
- VBI Vaccines Inc. VBIV surged 17.7% to close at $2.60. The stock has been volatile since the company last week announced FDA approval of PreHevbrio for the prevention of hepatitis B in adults.
- Huadi International Group Co., Ltd. HUDI surged 17.6% to close at $19.99.
- Delcath Systems, Inc. DCTH gained 17.4% to close at $8.45. Delcath Systems Gerard Michel acquired a total of 23200 shares at an average price of $8.61.
- Digital World Acquisition Corp. DWAC rose 16.6% to close at $51.07.
- Rent the Runway, Inc. RENT gained 16.6% to settle at $12.81.
- Vinco Ventures, Inc. BBIG rose 16.5% to close at $2.96.
- MongoDB, Inc. MDB gained 16.4% to settle at $499.82 after the company reported better-than-expected Q3results and issued FY22 guidance above estimates.
- Intellia Therapeutics, Inc. NTLA climbed 16.2% to close at $117.10.
- Trio-Tech International TRT surged 15.8% to settle at $9.00.
- Dermata Therapeutics, Inc. DRMA gained 15.5% to close at $2.54.
- Expensify, Inc. EXFY climbed 15.4% to close at $40.46. Expensify is expected to report third quarter financial results on Thursday, December 16, 2021.
- View, Inc. VIEW gained 15.3% to close at $4.67. View entered a strategic agreement with RXR Realty to combine the WorxWell data analytics platform into its technology stack.
- Designer Brands Inc. DBI rose 14.4% to settle at $15.45 as the company reported third-quarter FY21 sales growth of 30.7% year-on-year, to $853.47 million.
- BeyondSpring Inc. BYSI gained 13.6% to close at $4.67. BeyondSpring recently announced it received a Complete Response Letter from the FDA for the plinabulin NDA for prevention of chemotherapy-induced neutropenia.
- Momentive Global Inc. MNTV gained 12.5% to settle at $21.60. Legion Partners called on Momentive board to terminate proposed merger with Zendesk.
- Palatin Technologies, Inc. PTN gained 12.4% to close at $0.6186 after gaining around 5% on Monday.
- Vir Biotechnology, Inc. VIR shares gained 12% to settle at $42.98. GlaxoSmithKline said that its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data from preclinical studies.
- Yellow Corporation YELL climbed 11.3% to close at $13.83.
- CommScope Holding Company, Inc. COMM gained 10.8% to close at $11.32. Jefferies upgraded CommScope from Hold to Buy.
- Rafael Holdings, Inc. RFL rose 10.7% to close at $6.02. Rafael Holdings’ CEO and Chief Commercial Officer resigned last month.
- Moxian (BVI) Inc MOXC gained 9.8% to close at $4.38.
- Standard Lithium Ltd. SLI rose 9.7% to close at $9.40.
- Eqonex Limited EQOS climbed 9.1% to settle at $3.60.
- Allbirds, Inc. BIRD shares gained 9% to close at $16.05.
Check out these big penny stock gainers and losers
Losers
- Imperial Petroleum Inc. IMPP shares dropped 36.8% to close at $4.74.
- Insignia Systems, Inc. ISIG dipped 31% to close at $10.38. Insignia Systems shares jumped 200% on Monday after the company announced the commencement of a formal process to explore strategic options to maximize shareholder value, including potential merger or acquisition.
- AeroVironment, Inc. AVAV shares fell 27.5% to close at $57.98 on Tuesday after the company reported worse-than-expected Q2 sales results and issued FY22 guidance below analyst estimates.
- HealthEquity, Inc. HQY shares fell 24.6% to settle at $42.73 after the company reported worse-than-expected Q3 sales results and issued FY22 guidance below estimates. Raymond James downgraded HealthEquity from Strong Buy to Outperform and lowered the price target from $90 to $70.
- Pear Therapeutics, Inc. PEAR dipped 20% to close at $8.00.
- Xilio Therapeutics, Inc. XLO fell 19.3% to settle at $9.69.
- Cumberland Pharmaceuticals Inc. CPIX fell 17.6% to close at $5.72 after climbing more than 51% on Monday.
- Save Foods, Inc. SVFD dropped 14.7% to settle at $4.98. Save Foods highlighted its first commercial sales of its treatment of Medjool dates in Arava region in Israel.
- P3 Health Partners Inc. PIII fell 12.6% to close at $9.40.
- Arqit Quantum Inc. ARQQ dropped 11.8% to settle at $23.88.
- Patrick Industries, Inc. PATK fell 10.4% to close at $77.01 after reporting a proposed offering of $225,000,000 convertible senior notes due 2028.
- GitLab Inc. GTLB fell 8.3% to close at $81.74 after the company posted Q3 results and issued Q4 forecast.
- Aerie Pharmaceuticals, Inc. AERI dropped 8.3% to close at $9.76. Aerie Pharmaceuticals and Santen entered into an exclusive development and commercialization agreement for Rhopressa/Rhokiinsa (netarsudil ophthalmic solution) and Rocklatan/Roclanda (netarsudil and latanoprost ophthalmic solution).
ARQQArqit Quantum Inc
$29.399.99%
ATERAterian Inc
$2.293.15%
AVAVAeroVironment Inc
$180.62-0.53%
BBIGVinco Ventures Inc
$0.00100-95.0%
BIRDAllbirds Inc
$6.705.35%
BYSIBeyondSpring Inc
$1.70-2.02%
COMMCommScope Holding Co Inc
$5.61-4.18%
CPIXCumberland Pharmaceuticals Inc
$2.45-1.95%
DBIDesigner Brands Inc
$5.66-1.14%
DCTHDelcath Systems Inc
$15.94-1.18%
DRMADermata Therapeutics Inc
$1.200.84%
DSGNDesign Therapeutics Inc
$5.05-1.37%
ELEVElevation Oncology Inc
$0.67181.40%
EXFYExpensify Inc
$3.515.41%
GTLBGitLab Inc
$64.891.49%
HQYHealthEquity Inc
$106.892.08%
HUDIHuadi International Group Co Ltd
$1.660.88%
IMPPImperial Petroleum Inc
$2.85-1.72%
JMIAJumia Technologies AG
$4.042.41%
MDBMongoDB Inc
$261.680.41%
MGTXMeiraGTx Holdings PLC
$6.171.65%
NEONNeonode Inc
$8.680.58%
NMRDNemaura Medical Inc
$0.000001-%
NTLAIntellia Therapeutics Inc
$11.411.06%
NVAXNovavax Inc
$9.630.89%
PATKPatrick Industries Inc
$95.610.30%
PIIIP3 Health Partners Inc
$0.20805.10%
PTNPalatin Technologies Inc
$0.96992.09%
RENTRent the Runway Inc
$8.54-0.76%
RFLRafael Holdings Inc
$2.201.83%
SLIStandard Lithium Corp
$1.663.11%
STABStatera BioPharma Inc
$0.00010-%
SYTASiyata Mobile Inc
$5.932.42%
TRTTrio-Tech International
$5.75-3.68%
TRUPTrupanion Inc
$50.053.64%
VAXXVaxxinity Inc
--%
VIRVir Biotechnology Inc
$10.83-3.30%
XLOXilio Therapeutics Inc
$0.83981.22%
XYFX Financial
$7.802.50%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in